News & Updates

Dapagliflozin prevents worsening heart failure, CV death
Dapagliflozin prevents worsening heart failure, CV death
06 Oct 2022

Dapagliflozin is a safe treatment to reduce the risk of worsening heart failure (HF) or cardiovascular death both in patients with and without history of recent HF hospitalization, a study has shown.

Dapagliflozin prevents worsening heart failure, CV death
06 Oct 2022
Trans fatty acid intake tied to hypertensive disorders of pregnancy
Trans fatty acid intake tied to hypertensive disorders of pregnancy
05 Oct 2022